Vireo Growth (VREOF) Receivables (2020 - 2026)
Vireo Growth's (VREOF) quarterly Receivables came in at $14.1 million in Q1 2026, up 804.45% year-on-year from $1.6 million in Q1 2025, and up 1181.82% quarter-over-quarter from $1.1 million in Q4 2025.
Vireo Growth (VREOF) Receivables (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Receivables across 7 years of filings, most recently posting $14.1 million for Q1 2026.
- Receivables for Q1 2026 came in at $14.1 million, up 804.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.1 million (up 804.45% YoY), and the FY2025 annual result was $1.1 million, down 36.05% from the prior year.
- Receivables came in at $14.1 million for Q1 2026 at Vireo Growth, up from $1.1 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $14.1 million in Q1 2026 to a low of $829877.0 in Q4 2023.
- The 5-year median for Receivables is $3.6 million (2023), against an average of $4.7 million.
- Across the five-year window, Receivables soared 13712.15% in 2022 and sank 60.85% in 2025, its largest moves.
- Vireo Growth's Receivables stood at $1.4 million in 2022, then tumbled by 41.6% to $829877.0 in 2023, then soared by 107.28% to $1.7 million in 2024, then sank by 36.05% to $1.1 million in 2025, then soared by 1181.82% to $14.1 million in 2026.
- The last three Receivables figures came in at $14.1 million (Q1 2026), $1.1 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 149.62 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 355.67 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 14.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 11.19 Mn |
| Jun 30, 2025 | 9.14 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 1.72 Mn |
| Sep 30, 2024 | 8.07 Mn |
| Jun 30, 2024 | 6.82 Mn |
| Mar 31, 2024 | 3.98 Mn |
| Dec 31, 2023 | 829,877.00 |
| Sep 30, 2023 | 3.63 Mn |
| Jun 30, 2023 | 2.86 Mn |
| Mar 31, 2023 | 4.26 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 5.91 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 233,526.00 |
| Sep 30, 2021 | 42,796.00 |
| Jun 30, 2021 | 2.44 Mn |